Join the Biomarker Discovery and Validation in Progressive Supranuclear Palsy (PSP) study. The purpose of the study is to improve the diagnosis and treatment of parkinsonism, and to help discover the differences in proteins in your body fluids that are unique and different from those in Parkinson's disease and PSP.
Healthy volunteers should not have ever had a Parkinson's or progressive supranuclear palsy diagnosis. Participation requires three visits over two years with modest compensation for your time and travel, including free parking and lunch provided.
If you are interested in participating, contact AJ Hall by phone at 410-616-2813 or by email at email@example.com.
Johns Hopkins investigators: PI Alexander Pantelyat, Liana Rosenthal